Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Taysha Gene Therapies Receives Breakthrough Therapy Designation and Reports Regulatory Progress on TSHA-102 in Rett Syndrome
Friday, October 03, 2025Taysha Gene Therapies has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to TSHA its investigational gene therapy for Rett syndrome
Bristol Myers Squibb’s Alzheimer’s Candidate BMS-986446 Receives FDA Fast Track Designation
Friday, October 03, 2025Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has granted Fast Track Designation to BMS an investigational antibody targeting the microtubule binding region of tau MTBRtau
BenchSci Enters into Partnership with Thermo Fisher Scientific to Advance AI-Powered R&D Tools
Wednesday, October 01, 2025BenchSci has entered into a strategic partnership with Thermo Fisher Scientific to develop artificial intelligence AIdriven tools aimed at improving research and development productivity in the life sciences sector
Labcorp Partners with Roche to Strengthen Digital Pathology Capabilities
Wednesday, October 01, 2025Labcorp has entered into a collaboration with Roche to expand its digital pathology offering through the use of Roches FDAcleared VENTANA DP and DP slide scanners
AbbVie Begins Construction of New Active Pharmaceutical Ingredient Facility in North Chicago
Tuesday, September 30, 2025AbbVie has started building a new active pharmaceutical ingredient API manufacturing facility in North Chicago IllinoisThe development marks an important step in the companys plan to strengthen its manufacturing network in the United States
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy
Tuesday, September 30, 2025Dyne Therapeutics has received Orphan Drug designation in Japan for DYNE an investigational therapy for individuals with Duchenne muscular dystrophy DMD who have mutations in the DMD gene amenable to exon skipping
Integrated DNA Technologies Introduces New Enhancer Protein to Advance CRISPR-Based Therapies
Friday, September 26, 2025Integrated DNA Technologies IDT has launched the AltR HDR Enhancer Protein a new tool designed to improve the efficiency of homologydirected repair HDR in difficulttoedit cells such as induced pluripotent stem cells iPSCs and haematopoietic stem and...
Biostar Pharma Receives FDA Orphan Drug Designation for Utidelone in Pancreatic Cancer
Friday, September 26, 2025Biostar Pharma has received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for Utidelone in the treatment of pancreatic cancerPancreatic cancer remains one of the most aggressive and difficulttotreat malignancies with vague...
Cellectar and Evestia Clinical Partner to Advance Trial of Radiopharmaceutical in Triple-Negative Breast Cancer
Thursday, September 25, 2025Cellectar Biosciences has entered into a partnership with Evestia Clinical to support a Phase b trial of CLR in triplenegative breast cancer TNBCTriplenegative breast cancer accounts for around per cent of breast cancer cases in the United States I...
Er-Kim Enters into Agreement with Sentynl Therapeutics to Distribute Nulibry® and Zokinvy® in Europe
Thursday, September 25, 2025ErKim has entered into a commercialisation agreement with Sentynl Therapeutics to distribute Nulibry fosdenopterin and Zokinvy lonafarnib in several countries across Central and Eastern Europe the Mediterranean and Eurasia
